Skip to main content

Main navigation (without target group)

CONTACT
CHOOSE LANGUAGE

ALPROLIX®

Sellel veebisaidil olev teave on mõeldud Euroopa Liidu (EL) patsientidele, kellele on kirjutatud välja ravimit Alprolix®

KASUTUSTINGIMUSED

Footer Menu

Cookie Policy
Privacy Policy
Terms of Use

Marketing Authorisation Holder:

Swedish Orphan Biovitrum AB (publ)
SE-112 76 Stockholm, Sweden
Phone: +46 8 697 20 00
Reg.No. 556038-9321

Website updated: 2024-11-01